Back to top

Ligand price target raised to $388 from $266 at BofA

BofA analyst Jason Zemansky raised the firm’s price target on Ligand (LGND) to $388 from $266 and keeps a Buy rating on the shares. Despite strong ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ligand Pharmaceuticals Incorporated (LGND)